Bone marrow disease is any condition that disrupts your bone marrow’s ability to produce healthy blood cells. Since bone marrow is the factory for virtually all your blood cells, these diseases can affect everything from oxygen delivery to immune defense to wound healing. The term covers a wide range of conditions, from cancers like leukemia and multiple myeloma to production failures like aplastic anemia.
What Bone Marrow Actually Does
Bone marrow is the soft, spongy tissue inside your larger bones. Its primary job is hematopoiesis: the continuous production of three types of blood cells your body depends on every second of the day.
- Red blood cells carry oxygen from your lungs to every tissue in your body and shuttle carbon dioxide back to your lungs so you can exhale it.
- White blood cells fight infections, destroy germs, and eliminate abnormal cells. There are several subtypes, including neutrophils, lymphocytes, and monocytes, each handling different threats.
- Platelets are sticky cell fragments that clump together at injury sites to form clots, sealing damaged tissue so you don’t lose too much blood.
All three cell types originate from stem cells in the marrow. When disease strikes, it targets either the stem cells themselves or the process that turns them into mature, functioning blood cells.
Major Types of Bone Marrow Disease
Bone marrow diseases generally fall into a few categories based on what goes wrong: the marrow produces abnormal cells, produces too many cells, produces too few cells, or gets invaded by disease from elsewhere in the body.
Leukemia
In leukemia, the bone marrow produces abnormal white blood cells that don’t function properly and crowd out healthy cells. It can be acute (fast-growing) or chronic (slow-developing), and it’s classified further by the specific type of white blood cell involved. Leukemia is one of the more common bone marrow cancers, with acute myeloid leukemia and related cancers occurring at a rate of roughly 27 to 35 cases per million people annually in the U.S. and Europe.
Multiple Myeloma
Myeloma targets plasma cells, a type of white blood cell that normally produces antibodies. In multiple myeloma, cancerous plasma cells multiply in the bone marrow and produce abnormal proteins that can damage bones, kidneys, and other organs. The disease often reveals itself through a specific pattern of problems: high calcium levels in the blood, kidney damage, anemia, and bone lesions that weaken the skeleton. These four features are so central to diagnosis that doctors use them as a standard checklist.
Myelodysplastic Syndromes
In myelodysplastic syndromes (MDS), blood cells don’t mature properly. Instead of developing into functional cells, they die in the marrow or shortly after entering the bloodstream. Over time, defective cells outnumber healthy ones, leaving the body short on working blood cells. Most cases have no identifiable cause, though some are triggered by prior cancer treatments like chemotherapy and radiation, or by exposure to toxic chemicals such as benzene. MDS is more common than many people realize. Estimates suggest 35,000 to 55,000 new cases occur annually in the United States, though many go undiagnosed.
Aplastic Anemia
Aplastic anemia occurs when the bone marrow essentially stops producing enough blood cells across the board. In severe cases, the marrow’s cellularity drops below 25% of normal, meaning the tissue that should be packed with developing cells is instead largely empty. This leaves patients dangerously low on red blood cells, white blood cells, and platelets simultaneously. It’s relatively rare, affecting only 2 to 6 people per million in the U.S. and Europe, but it can be life-threatening without treatment.
Myeloproliferative Disorders
These are essentially the opposite of aplastic anemia. The marrow overproduces one or more types of blood cells. Too many white blood cells, red blood cells, or platelets can thicken the blood, cause clotting problems, and eventually lead to more serious complications including progression to leukemia.
Symptoms to Recognize
Because bone marrow diseases affect blood cell production, symptoms tend to mirror whichever cell line is most disrupted. The tricky part is that many of these symptoms are vague and overlap with dozens of other conditions, which is why bone marrow disease often isn’t the first thing anyone suspects.
When red blood cell counts drop, you develop anemia. That means persistent fatigue, pale skin, shortness of breath, and in severe cases, signs of heart strain as your cardiovascular system works harder to compensate for reduced oxygen delivery.
When platelet counts fall (a condition called thrombocytopenia), bleeding becomes a problem. You may notice tiny red or purple dots on your skin called petechiae, unexplained bruising, bleeding gums, or frequent nosebleeds. Cuts may take unusually long to stop bleeding.
When white blood cell counts drop, particularly a subtype called neutrophils, your immune system can’t fight off infections effectively. Recurrent fevers, skin infections, pneumonia, and even sepsis can become complications. Some patients find themselves getting sick far more often than usual, or struggling to recover from infections that would normally resolve quickly.
Certain inherited forms of bone marrow failure carry additional physical signs. Fanconi anemia, for example, can present with absent thumbs, short stature, kidney abnormalities, and unusual skin pigmentation patterns including café-au-lait spots.
How Bone Marrow Disease Is Diagnosed
Diagnosis usually starts with blood tests that reveal abnormal cell counts. But confirming the specific disease almost always requires looking directly at the marrow itself through two complementary procedures: aspiration and biopsy.
In a bone marrow aspiration, a hollow needle is inserted through bone (usually the back of the hipbone) and a syringe draws out a sample of the marrow’s liquid portion. This fluid lets doctors examine individual cells under a microscope, checking for abnormal shapes, sizes, and proportions. In a bone marrow biopsy, a slightly larger needle collects a small cylindrical core of the solid marrow tissue. This shows how the cells are arranged in their natural structure and how densely packed (or empty) the marrow is. Both samples are typically taken during the same visit, from the same site. In rare cases, the breastbone may be used for aspiration, and in very young children, the lower leg bone is sometimes the collection point.
Beyond microscopy, these samples undergo genetic testing, flow cytometry (which identifies cell types based on their surface markers), and other specialized analyses that help pinpoint the exact disease and its subtype.
Treatment Options
Treatment depends heavily on which specific disease is involved, how advanced it is, and the patient’s overall health. Some bone marrow diseases are managed with medications that stimulate normal cell production or suppress an overactive immune system that may be attacking the marrow. Others require chemotherapy to destroy abnormal cells and make room for healthy ones to grow.
For many serious bone marrow diseases, a stem cell transplant (sometimes still called a bone marrow transplant) is the most definitive treatment. There are three types. In an autologous transplant, your own stem cells are collected before intensive treatment and then returned to your body afterward. In an allogeneic transplant, stem cells come from a donor, either a family member or an unrelated person whose cells are a close enough genetic match. In the rare case of identical twins, a syngeneic transplant uses cells from the twin, which eliminates the risk of rejection.
Which type of transplant is appropriate, or whether one is recommended at all, depends on several factors: the specific disease, how advanced it is, whether your own stem cells are healthy enough to use, whether a suitable donor exists, and whether your body can tolerate the intensive chemotherapy that precedes the transplant. Age and overall fitness play a significant role, since the preparatory treatment is demanding. Some patients, particularly older adults with slower-progressing diseases like certain forms of MDS, may be better served by less aggressive approaches such as transfusions, growth factor injections, or targeted medications that manage symptoms and slow progression without the risks of transplant.